logo-loader
viewHavn Life

Havn Life Sciences closes financing bringing in over 11 million dollars to treasury

Havn Life Sciences (CSE: HAVN) CEO Tim More joined Steve Darling from Proactive to bring news the company has completed their recent financing that was well supported with the company adding 11.5 million to the treasury.

Moore talks about the demand from investors and he also talked about a milestone for the company this year,  when their natural health products, will be on store shelves in the Nesters Super Market chain.

Quick facts: Havn Life

Price: 0.91 CAD

CSE:HAVN
Market: CSE
Market Cap: $60.94 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Medexus begins selling tumor imaging powder Gleolan in Canadian full...

Medexus Pharmaceuticals Inc (TSXV:MDP) (OTCQX:MEDXF) (FRA:P731) CEO Ken d’Entremont tells Proactive it has initiated the Canadian commercial launch of Gleolan, a powder-based optical imaging agent taken orally by patients to help surgeons identify brain and spinal cord tumors called...

18 hours, 11 minutes ago

2 min read